These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
312 related items for PubMed ID: 35236285
21. Lectin-like oxidized low density lipoprotein receptor 1-deficient mice show resistance to instability-induced osteoarthritis. Hashimoto K, Mori S, Oda Y, Nakano A, Sawamura T, Akagi M. Scand J Rheumatol; 2016 Oct; 45(5):412-22. PubMed ID: 26901593 [Abstract] [Full Text] [Related]
22. Adhesion molecule expression in fibroblasts: alteration in fibroblast biology after transfection with LOX-1 plasmids. Chen K, Chen J, Liu Y, Xie J, Li D, Sawamura T, Hermonat PL, Mehta JL. Hypertension; 2005 Sep; 46(3):622-7. PubMed ID: 16116044 [Abstract] [Full Text] [Related]
23. Role of Ox-LDL and LOX-1 in Atherogenesis. Kattoor AJ, Kanuri SH, Mehta JL. Curr Med Chem; 2019 Sep; 26(9):1693-1700. PubMed ID: 29737246 [Abstract] [Full Text] [Related]
24. Effects of flow on LOX-1 and oxidized low-density lipoprotein interactions in brain endothelial cell cultures. Mao X, Xie L, Greenberg DA. Free Radic Biol Med; 2015 Dec; 89():638-41. PubMed ID: 26462413 [Abstract] [Full Text] [Related]
25. Rapamycin Inhibits Oxidized Low Density Lipoprotein Uptake in Human Umbilical Vein Endothelial Cells via mTOR/NF-κB/LOX-1 Pathway. Zhou YD, Cao XQ, Liu ZH, Cao YJ, Liu CF, Zhang YL, Xie Y. PLoS One; 2016 Dec; 11(1):e0146777. PubMed ID: 26752047 [Abstract] [Full Text] [Related]
26. Klotho ameliorates oxidized low density lipoprotein (ox-LDL)-induced oxidative stress via regulating LOX-1 and PI3K/Akt/eNOS pathways. Yao Y, Wang Y, Zhang Y, Liu C. Lipids Health Dis; 2017 Apr 13; 16(1):77. PubMed ID: 28407763 [Abstract] [Full Text] [Related]
27. UHRF1 inhibition mitigates vascular endothelial cell injury and ameliorates atherosclerosis in mice via regulating the SMAD7/YAP1 axis. Li W, Bai P, Li W. Mol Immunol; 2024 Jun 13; 170():119-130. PubMed ID: 38657333 [Abstract] [Full Text] [Related]
28. LOX-1, the Common Therapeutic Target in Hypercholesterolemia: A New Perspective of Antiatherosclerotic Action of Aegeline. Singh A, Srinivasan AK, Chakrapani LN, Kalaiselvi P. Oxid Med Cell Longev; 2019 Jun 13; 2019():8285730. PubMed ID: 31885819 [Abstract] [Full Text] [Related]
29. Liraglutide ameliorates oxidized LDL-induced endothelial dysfunction by GLP-1R-dependent downregulation of LOX-1-mediated oxidative stress and inflammation. Ying W, Meiyan S, Wen C, Kaizu X, Meifang W, Liming L. Redox Rep; 2023 Dec 13; 28(1):2218684. PubMed ID: 37278349 [Abstract] [Full Text] [Related]
30. The oxidized-LDL/LOX-1 axis in tumor endothelial cells enhances metastasis by recruiting neutrophils and cancer cells. Tsumita T, Maishi N, Annan DA, Towfik MA, Matsuda A, Onodera Y, Nam JM, Hida Y, Hida K. Int J Cancer; 2022 Sep 15; 151(6):944-956. PubMed ID: 35608341 [Abstract] [Full Text] [Related]
31. LOX-1 in macrophage migration in response to ox-LDL and the involvement of calpains. Wang X, Ding Z, Lin J, Guo Z, Mehta JL. Biochem Biophys Res Commun; 2015 Nov 06; 467(1):135-9. PubMed ID: 26393906 [Abstract] [Full Text] [Related]
32. Oxidized low-density lipoprotein attenuated desmoglein 1 and desmocollin 2 expression via LOX-1/Ca(2+)/PKC-β signal in human umbilical vein endothelial cells. Li YB, Zhang QH, Chen Z, He ZJ, Yi GH. Biochem Biophys Res Commun; 2015 Nov 06; 468(1-2):380-6. PubMed ID: 26498522 [Abstract] [Full Text] [Related]
33. LOX-1 receptor: A potential link in atherosclerosis and cancer. Balzan S, Lubrano V. Life Sci; 2018 Apr 01; 198():79-86. PubMed ID: 29462603 [Abstract] [Full Text] [Related]
34. Ginkgolide B ameliorates oxidized low-density lipoprotein-induced endothelial dysfunction via modulating Lectin-like ox-LDL-receptor-1 and NADPH oxidase 4 expression and inflammatory cascades. Feng Z, Yang X, Zhang L, Ansari IA, Khan MS, Han S, Feng Y. Phytother Res; 2018 Dec 01; 32(12):2417-2427. PubMed ID: 30136446 [Abstract] [Full Text] [Related]
35. Lectin-like oxidized low-density lipoprotein receptor-1 promotes endothelial dysfunction in LDL receptor knockout background. Hofmann A, Brunssen C, Poitz DM, Langbein H, Strasser RH, Henle T, Ravens U, Morawietz H. Atheroscler Suppl; 2017 Nov 01; 30():294-302. PubMed ID: 29096854 [Abstract] [Full Text] [Related]
36. Exploring the druggability of oxidized low-density lipoprotein (ox-LDL) receptor, LOX-1, a proatherogenic drug target involved in atherosclerosis. Tomar A, Sahoo S, Aathi M, Kuila S, Khan MA, Ravi GRR, Jeyaraman J, Mehta JL, Varughese KI, Arockiasamy A. Biochem Biophys Res Commun; 2022 Oct 01; 623():59-65. PubMed ID: 35872543 [Abstract] [Full Text] [Related]
37. Loxin Reduced the Inflammatory Response in the Liver and the Aortic Fatty Streak Formation in Mice Fed with a High-Fat Diet. Reyes C, Nova-Lamperti E, Duran-Sandoval D, Rojas D, Gajardo J, Guzman-Gutierrez E, Bustos-Ruiz C, Ormazábal V, Zúñiga FA, Escudero C, Aguayo C. Int J Mol Sci; 2022 Jun 30; 23(13):. PubMed ID: 35806336 [Abstract] [Full Text] [Related]
38. Intervention of Tongxinluo capsule against vascular lesion of atherosclerosis and its effect on lectin-like oxidized low density lipoprotein receptor-1 expression in rabbits. Yu YH, Xu XQ, Wang Y, Sun SZ, Chen Y. Chin J Integr Med; 2006 Mar 30; 12(1):32-6. PubMed ID: 16571281 [Abstract] [Full Text] [Related]
39. Epac1 (Exchange Protein Directly Activated by cAMP 1) Upregulates LOX-1 (Oxidized Low-Density Lipoprotein Receptor 1) to Promote Foam Cell Formation and Atherosclerosis Development. Robichaux WG, Mei FC, Yang W, Wang H, Sun H, Zhou Z, Milewicz DM, Teng BB, Cheng X. Arterioscler Thromb Vasc Biol; 2020 Dec 30; 40(12):e322-e335. PubMed ID: 33054390 [Abstract] [Full Text] [Related]
40. Modulation of oxidized-LDL receptor-1 (LOX1) contributes to the antiatherosclerosis effect of oleanolic acid. Jiang Q, Wang D, Han Y, Han Z, Zhong W, Wang C. Int J Biochem Cell Biol; 2015 Dec 30; 69():142-52. PubMed ID: 26510581 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]